ReviewPrzeglad gastroenterologiczny2023

Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review.

Ewelina Jakielska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.